Quinonic derivatives active against Toxoplasma gondii

Parasitology Research

Volumn 88, Issue 11, 2002, Pages 969-971

  Sarciron, Marie Elisabeth ^a   Nebois, Pascal ^a   Pautet, Félix ^a   Pétavy, Anne Françoise ^a   Fillion, Houda ^a   Walchshofer, Nadia ^a  

^a UNIVERSITÉ LYON 1   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ATOVAQUONE; CLINDAMYCIN; PYRIMETHAMINE; QUINONE DERIVATIVE; SULFADIAZINE;

ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; DRUG POTENCY; GROWTH INHIBITION; HUMAN; HUMAN CELL; INCUBATION TIME; MICROBIAL GROWTH; NONHUMAN; PRIORITY JOURNAL; TOXOPLASMA GONDII;

ANIMALS; ANTIPROTOZOAL AGENTS; CELL LINE; HUMANS; INHIBITORY CONCENTRATION 50; PARASITIC SENSITIVITY TESTS; QUINONES; STRUCTURE-ACTIVITY RELATIONSHIP; TOXOPLASMA;

PROTOZOA; TOXOPLASMA GONDII;

EID: 0036399320     PISSN: 09320113     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00436-002-0615-6     Document Type: Article

References (17)

1. Araujo FG, Huskinson J, Remington JS (1991) Remarkable in vitro and in vivo activities of the hydroxynaphthoquinone 566C80 against tachyzoites and tissue cysts of Toxoplasma gondii. Antimicrob Agents Chemother 35:293-299
2. Araujo FG, Huskinson-Mark J, Gutteridge WE, Remington JS (1992) In vitro and in vivo activities of the hydroxynaphthoquinone 566C80 against the cyst form of Toxoplasma gondii. Antimicrob Agents Chemother 36:326-330
3. Bolton JL, Trush MA, Penning TM, Dryhurst G, Monks TJ (2000) Role of quinones in toxicology. Chem Res Toxicol 13:135-60
4. Cauchetier E, Paul M, Rivollet D, Fessi H, Astier A, Deniau M (2000) Therapeutic evaluation of free and liposome-encapsulated atovaquone in the treatment of murine leishmaniasis. Int J Parasitol 30:777-783
5. Chaker L, Pautet F, Fillion H (1995) Diels-Alder reactions of a hydrazonocrotonate with bromonaphthoquinones. Heterocycles 41:1169-1179
6. Chan C, Montaner J, Lefebvre EA, Morey G, Dohn M, McIvor RA, Scott J, Marina R, Caldwell P (1999) Atovaquone suspension compared with aerolized pentamidine for prevention of Pneumocystis carinii pneumonia in human immunodeficiency virus-infected subjects intolerant of trimethoprim or sulfonamides. J Infect Dis 180:369-376
7. Gray JS, Pudney M (1999) Activity of atovaquone against Babesia microti in the Mongolian gerbil, Meriones unguiculatus. J Parasitol 85:723-728
8. Hartup C, Johnson JD, Holliman RE (1997) The investigation of Toxoplasma infection associated with pregnancy. J Infect 35:47-54
9. Johnson MG, Kiyokawa H, Tani S, Koyama J, Morris-Natschke SL, Mauger A, Bowers-Daines MM, Lange BC, Lee KH (1997) Antitumor agents - CLXVII. Synthesis and structure-activity correlations of the cytotoxic anthraquinone 1,4-bis-(2,3-ep-oxypropylamino)-9,10-anthracenedione, and of related compounds. Bioorg Med Chem 5:1469-1479
10. Knecht W, Löffler M (2000) Redoxal as a new lead structure for dihydroorotate dehydrogenase inhibitors: a kinetic study of the inhibition mechanism. FEBS Lett 467:27-30
11. 0 domain mutations as a mechanism of atovaquone-resistance. Mol Biochem Parasitol 108:1-12
12. Nebois P, Sarciron ME, Bibal B, Bouammali B, Cherkaoui O, Pautet F, Pétavy AF, Walchshofer N, Fillion H (2000) Quinonic derivatives active against a virulent strain of Toxoplasma gondii. Synthesis of 2-methylfuro[2,3-g]- and [3,2-g]isoquino-linetriones. Bioorg Med Chem Lett 10:871-873
13. Romand S, Pudney M, Derouin F (1993) In vitro and in vivo activities of the hydroxynaphthoquinone atovaquone alone or combined with pyrimethamine, sulfadiazine, clarithromycin, or minocycline against Toxoplasma gondii. Antimicrob Agents Chemother 37:2371-2378
14. Suresh K, Howe J, Ng GC, Ho LC, Ramachandran NP, Loh AK, Yap EH, Singh M (1994) A multiple fission-like mode of asexual reproduction in Blastocystis hominis. Parasitol Res 80:523-527
15. USPHS/IDSA (1999) Guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus. Morbid Mortal Wkly Rpt 48:1-59, 61-66
16. Van den Berg JD, Duvenage CS, Roskell NS, Scott TR (1999) Safety and efficacy of atovaquone and proguanil hydrochloride for the prophylaxis of Plasmodium falciparum malaria in South Africa. Clin Ther 21:741-749
17. Watt G (2000) Atovaquone-proguanil for falciparum malaria in the Philippines. J Infect Dis 181:405